Comparing fixation location and stability in patients with neovascular age-related macular degeneration treated with or without Ranibizumab.

Journal article

PURPOSE: To compare fixation location and stability in patients with neovascular age-related macular degeneration (AMD) treated with or without ranibizumab. METHODS: Patients were recruited from the Macular Clinic of the King's College Hospital in London. Two groups of patients with neovascular AMD with at least 12 months of follow-up were included in the study. The treated group was treated with ranibizumab while the untreated group did not have any treatment. Best corrected visual acuity (...

Expand abstract

Authors: Pearce, E; Sivaprasad, S; Chong, N

• Publication status: Published
• Journal: Eye (London, England)
• Volume: 25
• Issue: 2
• Pages: 149-153
• Publication date: 2011-02-01
• DOI: 10.1038/eye.2010.167
• EISSN: 1476-5454
• ISSN: 0950-222X
• Language: English
• Keywords: Aged, 80 and over; Immunologic Factors; Antibodies, Monoclonal; Male; Macula Lutea; Fixation, Ocular; Aged; Visual Acuity; Macular Degeneration; Female; Tomography, Optical Coherence; Humans; Antibodies, Monoclonal, Humanized